A few updates on the Bredesen protocol

I’ve been absent from blogging here or on most of my other personal sites this year, due to stress and health issues, but feel like I might be on the comeback! Anyway, until I remember to follow up with whoever it was who offered to help me turn my three blogs into one, I’m posting a few links to a few positive articles on Professor Dale Bredesen’s protocol here.

Some of you will think it is misleading to publish what you may see as ‘false hope’, others will see this as fresh new hope. I’m in the latter of those baskets, and honestly believe it is the ONLY hope on the horizon for most people with either MCI or in the very early progressions of most of the diagnosed dementias. Some hope is better than no hope, which is how I’ve been feeling about research for a cure or as disease modifying drug or drugs for far too long, and also why I’ve fought so hard globally to get a balance in research into risk reduction and care, and not only a cure.

Dr Dave Jenkins

On another note of good news, on July 25(UK>USA)/26 (AU), DAI is hosting its monthly “A Meeting Of The Minds” Webinar with guest speaker, Dr Dave Jenkins, who is a medical doctor accredited in the Bredesen Protocol in Australia and New Zealand.  Keep your eyes open for the announcement, as registrations for this event will be live soon .

 

Bredesen Protocol

Dr. Dale Bredesen, of the Buck Institute for Research on Aging and UCLA’s Mary S. Easton Center for Alzheimer’s Disease Research, is a scientist who has been studying Alzheimer’s disease for 30 years and has come up with a way to reverse it in its early stages. His initial protocol involved 25 different interventions which individually don’t make a big difference, but together can provide powerful synergistic benefits.

Each intervention is tweaked over time by using blood tests, body measurements, imaging and similar guides to measure its effect. In his initial paper, nine out of ten patients reversed their memory problems and returned to their former healthy level of functioning. The one who didn’t show improvement was past the early stages of Alzheimer’s.

Dr. Bredesen has since expanded the protocol and number of patients seen. He is in the process of making it available to the wider public with the help of doctors certified in the protocol through MPI Cognition.

Do follow the link to read the full article, in particular the links to the things you can do at home, that may slow the progression of dementia, or even prevent it

Hope on the horizon

Dr Dale Bredesen says we need to measure our brain-health ­bio­markers in the same way we do cholesterol and blood pressure. His lifestyle programme to reverse memory decline could help revolutionise treatment for dementia, a disease he describes as an “emergency”.

Read the full article and the testimonial here…

The Bredesen Protocol™ Announces Progress in Reversal of Cognitive Decline in Alzheimer’s Disease

The inventor and developer of the original MEND protocol (metabolic enhancement for neurodegeneration), Dr. Dale Bredesen, has developed a more advanced and effective protocol, dubbed ReCODE™ for Reversal of Cognitive Decline. The MEND protocol was the first to result in the reversal of cognitive decline in patients with pre-Alzheimer’s conditions and early Alzheimer’s disease, as published in the journal Aging in 2014 by Dr. Bredesen.

“These new features greatly enhance our ability to determine the underlying causes of cognitive decline, and improve the accuracy of information, which helps our trained physicians reverse cognitive decline”

Read the full article on Business Wire here, and a summary here…

And finally, one more article worth reviewing;

Alzheimer’s Disease Amyloid Hypothesis Crumbling

“… At the very least, the amyloid hypothesis should be revisited and revised, in order “to reconcile data from recent drug failures.” There may even be a protective role for amyloid proteins. According to Dale Bredesen, MD, who has designed a multi-pronged diet and lifestyle protocol that has been shown to reverse Alzheimer’s and its precursor, mild cognitive impairment (MCI), in a small but extremely promising study, “The production of the amyloid is a protective response. […] The idea of just getting rid of the amyloid without understanding why it’s there actually makes very little biological sense.” Other researchers agree: they “propose that Aβ is a key regulator of brain homeostasis. During AD, while Aβ accumulation may occur in the long term in parallel with disease progression, it does not contribute to primary pathogenesis. This view predicts that amyloid-centric therapies will continue to fail, and that progress in developing successful alternative therapies for AD will be slow until closer attention is paid to understanding the physiological function of Aβ and its precursor protein.”


2 thoughts on “A few updates on the Bredesen protocol

  1. Thanks for this Kate. I never think it is too late to try to reclaim aspects of cognitive decline as you will see from my Blog. Despite Maureen’s diagnosis being moderate to severe dementia we are still leaving ‘Prescribed Disengagement’ where it belongs: in the bin!

    Like

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s